11.09.17
Vetter, a provider of prefilled drug-delivery systems, has opened a new branch office in South Korea located in Songdo within the biologics cluster that houses numerous biopharma companies and service providers.
The company has been expanding in the Asia Pacific region, establishing its APAC hub in Singapore in 2014, and subsequently formed a Japanese subsidiary in Tokyo in 2015.
While Vetter had already been active in the South Korean market for years, the establishment of its own local branch office better positions the company to support its existing business there as well as new local and global customers, to support development, manufacturing and packaging requirements for injectable drugs.
“Today is yet another milestone for our company. This new office will allow us to directly serve both local and global companies with South Korean market interests,” said Vetter managing director Peter Soelkner. “We are certain that our market presence and activities in this market will serve as an additional base and contribution for Vetter’s future global organic growth.”
The company has been expanding in the Asia Pacific region, establishing its APAC hub in Singapore in 2014, and subsequently formed a Japanese subsidiary in Tokyo in 2015.
While Vetter had already been active in the South Korean market for years, the establishment of its own local branch office better positions the company to support its existing business there as well as new local and global customers, to support development, manufacturing and packaging requirements for injectable drugs.
“Today is yet another milestone for our company. This new office will allow us to directly serve both local and global companies with South Korean market interests,” said Vetter managing director Peter Soelkner. “We are certain that our market presence and activities in this market will serve as an additional base and contribution for Vetter’s future global organic growth.”
